Abstract
The commercial biocatalyst Novozym ® 435 was used for the kinetic resolution of (R/S)-ibuprofen through the esterification with short chain alcohols (ethanol, 1-propanol and 2-propanol) in the absence of organic co-solvent. The best enzymatic performance was obtained by employing ethanol as reagent and solvent. Due to the deleterious effect of this alcohol on the integrity of the commercial biocatalyst previously reported different organic co-solvents (isooctane, nhexane, carbon tetrachloride, ethyl acetate, acetonitrile and tetrahydrofuran) were screened in order to minimize the volume of ethanol to be used. Thus, the effect of the chemical nature of the co-solvent on enantioselective esterification of (R/S)-ibuprofen with ethanol was evaluated. The results show that the best performance was obtained with the reaction system without co-solvent added. Additionally, this investigation demonstrated the need to address multiple physicochemical properties of the solvents to analyze their effects on biocatalysis.
Keywords: Ibuprofen, Novozym435, Ethanol, Organic solvents.
Graphical Abstract
Current Catalysis
Title:Effect of Co-solvents in the Enantioselective Esterification of (R/S)- ibuprofen with Ethanol
Volume: 3
Author(s): Carla Jose, M. Victoria Toledo, Jaiver Osorio Grisales and Laura E. Briand
Affiliation:
Keywords: Ibuprofen, Novozym435, Ethanol, Organic solvents.
Abstract: The commercial biocatalyst Novozym ® 435 was used for the kinetic resolution of (R/S)-ibuprofen through the esterification with short chain alcohols (ethanol, 1-propanol and 2-propanol) in the absence of organic co-solvent. The best enzymatic performance was obtained by employing ethanol as reagent and solvent. Due to the deleterious effect of this alcohol on the integrity of the commercial biocatalyst previously reported different organic co-solvents (isooctane, nhexane, carbon tetrachloride, ethyl acetate, acetonitrile and tetrahydrofuran) were screened in order to minimize the volume of ethanol to be used. Thus, the effect of the chemical nature of the co-solvent on enantioselective esterification of (R/S)-ibuprofen with ethanol was evaluated. The results show that the best performance was obtained with the reaction system without co-solvent added. Additionally, this investigation demonstrated the need to address multiple physicochemical properties of the solvents to analyze their effects on biocatalysis.
Export Options
About this article
Cite this article as:
Jose Carla, Toledo Victoria M., Grisales Osorio Jaiver and Briand E. Laura, Effect of Co-solvents in the Enantioselective Esterification of (R/S)- ibuprofen with Ethanol, Current Catalysis 2014; 3 (2) . https://dx.doi.org/10.2174/2211544702666131230234058
DOI https://dx.doi.org/10.2174/2211544702666131230234058 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mast Cell-IgE-and Mast Cell-Structural Cell Interactions in Allergic Airway Disease
Current Drug Targets - Inflammation & Allergy Measurement of Palmitoylethanolamide and Other N-Acylethanolamines During Physiological and Pathological Conditions
CNS & Neurological Disorders - Drug Targets SUBJECT INDEX TO VOLUME 1
Current Pharmaceutical Biotechnology Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets Allergen-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
Current Pharmaceutical Design TRP Channels in Vascular Disorders
Current Topics in Medicinal Chemistry Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart’s Disease
Current Molecular Medicine Obstructive Sleep Apnea Syndrome: Implications in Cardiovascular Disease
Current Respiratory Medicine Reviews A Proprietary Topical Preparation Containing EGCG-Stearate and Glycerin with Inhibitory Effects on Herpes Simplex Virus: Case Study
Inflammation & Allergy - Drug Targets (Discontinued) Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma
Current Cancer Drug Targets Opioid-induced Cardioprotection
Current Pharmaceutical Design Renal & Ocular Targets for Therapy in Wegeners Granulomatosis
Inflammation & Allergy - Drug Targets (Discontinued) Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008
Current Topics in Medicinal Chemistry Positional Cloning in Mice and Its Use For Molecular Dissection of Inflammatory Arthritis
Current Pharmaceutical Biotechnology Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin
Current Pharmaceutical Design Atypical Chemokine Receptors in Inflammatory Disease
Current Molecular Medicine Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued)